Long‐Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy

@article{Guo2001LongTermVA,
  title={Long‐Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy},
  author={C. Y. Guo and Gabriel M Ronen and Stephanie A Atkinson},
  journal={Epilepsia},
  year={2001},
  volume={42}
}
Summary:  Purpose: To determine whether long‐term treatment with valproate (VPA) and/or lamotrigine (LTG) in children with epilepsy is associated with altered growth and/or bone metabolism. 
Valproate/Lamotrigine and Growth Retardation
TLDR
Growth and bone metabolism were evaluated in 27 boys and 26 girls with epilepsy treated with valproate and/or lamotrigine for >2 years, in a study at McMaster University and Children’s Hospital, Hamilton, Ontario, Canada.
Effect of levetiracetam and oxcarbazepine on 4‐year fragility fracture risk among prepubertal and pubertal children with epilepsy
TLDR
Two commonly prescribed antiseizure medications, levetiracetam (LEV) and oxcarbazepine (OXC), were associated with an increased risk of fragility fracture in children with epilepsy when initiating therapy during a crucial period of bone development, namely, pre- and midpuberty.
Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism
TLDR
The effect of Phenytoin and valproate and levetiracetam on bone mass, biomechanical strength, and bone turnover in rats is compared.
Endocrine Effects of Valproate in Adolescent Girls with Epilepsy
Summary:  Purpose: To investigate the effect of epilepsy and/or valproate (VPA) monotherapy on physical growth, weight gain, pubertal development, and hormonal status in adolescent girls with
Chronic antiepileptic monotherapy, bone metabolism, and body composition in non‐institutionalized children
TLDR
The influence of chronic monotherapy with antiepileptic drugs (AEDs) on vitamin D levels, bone metabolism, and body composition was determined.
Adverse effects of valproate on bone: Defining a model to investigate the pathophysiology
TLDR
This study aimed to characterize adverse bone effects of valproate and to identify mouse strains either resistant or sensitive to these effects.
Impaired bone and muscle development in young people treated with antiepileptic drugs
TLDR
Examination of bone, muscle, and balance outcomes in young patients taking AEDs found no significant differences in terms of bone density, balance impairment, or fracture risk in adults.
The Effect of Oxcarbazepine on Bone Metabolism
TLDR
This work investigated the effect of new antiepileptic drug, oxcarbazepine, on bone metabolism and found it to cause alteration in bone metabolism.
Bone Health in Women with Epilepsy
A 55-year-old woman has been on carbamazepine for 30 years with excellent control of her partial-onset seizures. In the past when an attempt was made to switch her to lamotrigine or levetiracetam,
Physical Growth and Endocrinal Disorders during Pubertal Maturation in Girls with Epilepsy
Summary:  Purpose: This study investigated the effect of epilepsy and/or antiepileptic drugs (AEDs) on the physical growth, pubertal development, and androgenic status of girls with epilepsy between
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 40 REFERENCES
Serum 25-Hydroxycalciferol Levels and Bone Mass in Children on Chronic Anticonvulsant Therapy
TLDR
Children with epilepsy receiving chronic therapy with phenobarbital or diphenylhydantoin or both and controls were studied to determine the effects of anticonvulsant therapy on seizures.
Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy
TLDR
It is suggested that drug-mediated enzyme induction may be the mechanism responsible by causing a greatly increased inactivation of vitamin D in these patients with epilepsy treated with long-term anticonvulsant therapy.
Effect of Antiepileptic Drugs on Bone Mineral Density in Children Between Ages 6 and 2 Years
TLDR
Reduced bone mineralization was observed in children with epilepsy, treated with sodium valproate even though treatment was for a rather short time, and there were no significant differences between the control and study patients.
Evaluation of bone mineral density in children receiving antiepileptic drugs.
TLDR
The effects of the valproic acid and carbamazepine monotherapies on bone mineral density were evaluated and values were not statistically different from that of the control group (P > 0.05).
The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.
TLDR
AEDs do not seem to have any adverse effects on linear growth or sexual maturation in girls with epilepsy, and VPA-related weight gain can be seen already in prepuberty and it is not associated with hyperinsulinemia in these young patients.
Strategies to protect bone mass in the older patient with epilepsy.
TLDR
The patient work-up, careful prescribing, and monitoring for drug toxicity can help preserve bone integrity in patients receiving antiepileptic drug therapy, and may exacerbate this problem by adversely affecting bone metabolism and increasing the risk of falls related to drug toxicity.
Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status.
TLDR
It is suggested that ambulatory status is more important than was recognized previously in relation to abnormalities in vitamin D, calcium, and bone statuses; that all nonambulatory children may be at risk for low serum calcidiol and osteopenia; and that routine monitoring of risk and consideration of prophylactic vitamin D supplementation are warranted.
Pathophysiology behind anticonvulsant osteomalacia.
TLDR
It has been shown that treatment with vitamin D2 increase BMC whereas serum calcium was unchanged, and findings suggest that vitamin D1 and D3 are metabolized differently in anticonvulsant treated patients.
Folate and mineral metabolism in poorly nourished epileptic children.
TLDR
Ninety poorly nourished, ambulant, epileptic children, who had been receiving anticonvulsant medications for at least one year, were studied in respect to their folic acid and vitamin D metabolism and height retardation did not correlate with abnormal mineral metabolism.
The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone.
TLDR
The occurrence of vitamin D deficiency in patients treated with anticonvulsant drugs resulting in hypocalcemia and secondary hyperparathyroidism is confirmed, and an oral vitamin D3 supplement is recommended.
...
1
2
3
4
...